安領國際(01410.HK)2025財年收益約7.34億港元 同比增加約17.4%
格隆匯6月23日丨安領國際(01410.HK)發佈公吿,集團2025財年錄得收益及毛利分別為約734.3百萬港元及約141.4百萬港元,同比分別增加約17.4%及約3.2%。
於2025財年,公司錄得公司擁有人應占溢利約24.5百萬港元(2024財年:約29.7百萬港元)。
撇除2025財年及2024財年內按公平值計入損益的金融資產的公平值變動及非經常性其他收益及虧損項目的影響,集團於2025財年錄得經調整淨溢利約18.2百萬港元,較2024財年的經調整公司擁有人應占虧損約0.4百萬港元轉虧為盈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.